FR2348704A1 - Procede de preparation d'un vaccin contre le virus de la rhinopneumonie equine et vaccin ainsi obtenu - Google Patents

Procede de preparation d'un vaccin contre le virus de la rhinopneumonie equine et vaccin ainsi obtenu

Info

Publication number
FR2348704A1
FR2348704A1 FR7712208A FR7712208A FR2348704A1 FR 2348704 A1 FR2348704 A1 FR 2348704A1 FR 7712208 A FR7712208 A FR 7712208A FR 7712208 A FR7712208 A FR 7712208A FR 2348704 A1 FR2348704 A1 FR 2348704A1
Authority
FR
France
Prior art keywords
vaccine
preparing
procedure
equine rhinopneumonia
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7712208A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philips Roxane Inc
Original Assignee
Philips Roxane Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Roxane Inc filed Critical Philips Roxane Inc
Publication of FR2348704A1 publication Critical patent/FR2348704A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/82—Viral vaccine for equine species, e.g. horses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7712208A 1976-04-23 1977-04-22 Procede de preparation d'un vaccin contre le virus de la rhinopneumonie equine et vaccin ainsi obtenu Withdrawn FR2348704A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/679,840 US4110433A (en) 1976-04-23 1976-04-23 Equine rhinopneumonitis virus

Publications (1)

Publication Number Publication Date
FR2348704A1 true FR2348704A1 (fr) 1977-11-18

Family

ID=24728588

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7712208A Withdrawn FR2348704A1 (fr) 1976-04-23 1977-04-22 Procede de preparation d'un vaccin contre le virus de la rhinopneumonie equine et vaccin ainsi obtenu

Country Status (14)

Country Link
US (1) US4110433A (enExample)
AU (1) AU2454077A (enExample)
BE (1) BE853810A (enExample)
DD (1) DD131762A5 (enExample)
DE (1) DE2717919A1 (enExample)
ES (1) ES458113A1 (enExample)
FR (1) FR2348704A1 (enExample)
GB (1) GB1570732A (enExample)
LU (1) LU77166A1 (enExample)
NL (1) NL7704239A (enExample)
NZ (1) NZ183907A (enExample)
PL (1) PL197579A1 (enExample)
SE (1) SE7704514L (enExample)
SU (1) SU700069A3 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis
US4636469A (en) * 1982-04-07 1987-01-13 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Isolation of hepatitis A virus strain HM-175
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
DE69131984T2 (de) * 1990-08-01 2000-07-06 Research Corp. Technologies, Inc. Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
EP1216054A1 (en) * 1999-09-10 2002-06-26 Akzo Nobel N.V. Equine herpes virus temperature sensitive mutant and live vaccine thereof
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6803041B2 (en) 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
WO2007115059A2 (en) 2006-03-29 2007-10-11 Merial Limited Vaccine against streptococci
CN114214289A (zh) * 2021-12-24 2022-03-22 山东省农业科学院畜牧兽医研究所 一株马冠状病毒ECoV464693及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2003343A1 (enExample) * 1968-03-06 1969-11-07 Behringwerke Ag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2003343A1 (enExample) * 1968-03-06 1969-11-07 Behringwerke Ag

Also Published As

Publication number Publication date
SE7704514L (sv) 1977-10-24
NZ183907A (en) 1979-10-25
SU700069A3 (ru) 1979-11-25
NL7704239A (nl) 1977-10-25
DD131762A5 (de) 1978-07-19
PL197579A1 (pl) 1978-09-25
DE2717919A1 (de) 1977-11-03
ES458113A1 (es) 1978-03-16
US4110433A (en) 1978-08-29
LU77166A1 (enExample) 1977-08-12
BE853810A (fr) 1977-10-21
AU2454077A (en) 1978-10-26
GB1570732A (en) 1980-07-09

Similar Documents

Publication Publication Date Title
GR62096B (en) Substituted n-phenyl-n'-benzoyl-urea,preparation process and use thereof as insecticides
IT1093503B (it) Fenossi-benzil-ossicarbonil-derivati sostituiti,procedimento per la loro preparazione e loro impiego come insetticidi e come acaricidi
FR2348704A1 (fr) Procede de preparation d'un vaccin contre le virus de la rhinopneumonie equine et vaccin ainsi obtenu
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
GR60791B (en) 2',3',6'-trichlor-4-cyano-4'-benzoylureido-diphenylether,preparation process and use thereof as insecticides
DE2961804D1 (en) N-(3-benzoylpropyl)-spiro-(dihydrobenzofuranpiperidines and -pyrrolidines), derivatives thereof, methods for their preparation and their use for medicines
TR20766A (tr) Asillendirilmis triazolil &-floropinakolil tuerevleri,bunlarin hazirlanmasi icin usuller ve bunlarin fungisid olarak kullanilmalari
ES496019A0 (es) Procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo
NL174345B (nl) Zuur alkalicitraat, werkwijze ter bereiding daarvan en therapeutisch preparaat.
DE3062268D1 (en) Alkoxybenzylpyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
MX5632E (es) Procedimiento mejorado para la preparacion de levo n-(1-etil-2-pirrolidinometil)-2-metoxi-5-sulfamoilbenzamida
RO81212A (ro) Procedeu pentru prepararea unor 2',6'-dialchil-n-(alcoximetil)2-cloracetanilide
DE2690724D1 (en) Substituted alkanyl-azolyl carbamates, process for their preparation and their use as insecticides, acaricides and nematocides
LU79503A1 (fr) Procede de preparation d'un vaccin syncytial du virus respiratoire
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines
SE7811593L (sv) 2,4-diamino-5-bensylpyrimidiner och forfarande for framstellning derav
MX5355E (es) Procedimiento para la preparacion del hemicetal 3 a alfa-h-4-alfa(3'-propanol)-7-a beta-metilhexahidro-1,5-indandiona
RO86358A2 (ro) Procedeu pentru prepararea unor 1,2,4-triazolil-u-il-propionitrili
AR211237A1 (es) Un procedimiento de preparacion de la n-(1'-alilpirrolidinil-2'-mentil)2-metoxi-4,5-azimidobenzamida
SE7714658L (sv) 1,4-oxatiner och forfarande for framstellning derav
MX4815E (es) Procedimiento para preparar 1,2',6'-tri-t-butoxicarbonil-fortimicina b
IT1130214B (it) 3, 4-epossipirrolidine 1-sostituite e procedimento per la loro preparazione
YU40275B (en) Process for preparing 9,10-dihydro-ergosine and physiologically tolerated acid addition salts thereof
IL55237A0 (en) P-substituted n,n'-bis phosphoramides and process for the preparation thereof
IT7824036A0 (it) Preparato medicinale con proprieta' d'assorbimento migliorata eprocedimento per prepararlo.

Legal Events

Date Code Title Description
ST Notification of lapse